Ptc Therapeutics (PTCT) Retained Earnings (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Retained Earnings of -$2.9 billion for Q2 2026, down 1.35% year-over-year from -$2.9 billion in Q2 2025, and up 2.81% quarter-over-quarter from -$3.0 billion in Q1 2026.
Ptc Therapeutics (PTCT) Retained Earnings (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Retained Earnings history runs 15 years deep, the most recent figure standing at -$2.9 billion for Q2 2026.
- In Q2 2026, Retained Earnings fell 1.35% year-over-year to -$2.9 billion; the TTM figure through Jun 2026 stood at -$2.9 billion (down 1.35% YoY), while the FY2025 annual figure was -$3.0 billion, up 18.72% from the prior year.
- Retained Earnings for Q2 2026 stood at -$2.9 billion, up from -$3.0 billion in the prior quarter.
- The five-year high for Retained Earnings was -$2.2 billion in Q1 2022, with the low at -$3.6 billion in Q4 2024.
- The 5-year median for Retained Earnings is -$2.9 billion (2025), against an average of -$3.0 billion.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings plunged 225.12% in 2022, then gained 20.99% in 2025.
- Ptc Therapeutics' Retained Earnings stood at -$2.7 billion in 2022, then slipped by 23.58% to -$3.3 billion in 2023, then retreated by 11.06% to -$3.6 billion in 2024, then gained by 18.72% to -$3.0 billion in 2025, then climbed by 2.72% to -$2.9 billion in 2026.
- Business Quant data shows PTCT's Retained Earnings at -$2.9 billion in Q2 2026, -$3.0 billion in Q1 2026, and -$3.0 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | -2.88 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.88 Bn |
| Mar 31, 2026 | 2.78 Bn |
| Dec 31, 2025 | -2.96 Bn |
| Sep 30, 2025 | 2.67 Bn |
| Jun 30, 2025 | 7.36 Mn |
| Mar 31, 2025 | -13.95 Mn |
| Dec 31, 2024 | -25.89 Mn |
| Sep 30, 2024 | 2.53 Bn |
| Jun 30, 2024 | -3.47 Bn |
| Mar 31, 2024 | -3.38 Bn |
| Dec 31, 2023 | 2.47 Bn |
| Sep 30, 2023 | -3.13 Bn |
| Jun 30, 2023 | -1.43 Mn |
| Mar 31, 2023 | 2.34 Bn |
| Dec 31, 2022 | -2.66 Bn |
| Sep 30, 2022 | -2.49 Bn |
| Jun 30, 2022 | 10.25 Mn |
| Mar 31, 2022 | -2.22 Bn |
| Dec 31, 2021 | 2.12 Bn |
| Sep 30, 2021 | -1.95 Bn |